Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) shares gapped up before the market opened on Friday. The stock had previously closed at $10.77, but opened at $11.19. Santen Pharmaceutical shares last traded at $11.19, with a volume of 129 shares.
Santen Pharmaceutical Stock Up 3.9%
The firm has a 50 day moving average price of $11.25 and a two-hundred day moving average price of $11.73.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription medicines and other products used to diagnose and treat eye diseases.
Its product portfolio includes ophthalmic treatments for conditions such as glaucoma, dry eye, allergic eye disease, ocular infections and retinal disorders. Santen also develops therapies for other vision-related conditions and provides products for eye-care professionals and patients.
Founded in 1890 and headquartered in Osaka, Japan, Santen serves patients and medical professionals through operations and commercial activities in Japan and international markets, including parts of Asia, Europe and other regions.
Featured Articles
- Five stocks we like better than Santen Pharmaceutical
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}